Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AMLCourtney D. DiNardo, Hagop M. Kantarjian, Gabrielle T. Prince et al.|New England Journal of Medicine|2018Cited by 1.4k
Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and CyclophosphamideGeorge W. Santos, Andrew M. Yeager, P. J. Tutschka et al.|New England Journal of Medicine|1983Cited by 818
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemiaStephen H. Petersdorf, Frederick R. Appelbaum, Kenneth J. Kopecky et al.|Blood|2013Cited by 632
Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-HydroperoxycyclophosphamideAndrew M. Yeager, John R. Wingard, Herbert Kaizer et al.|New England Journal of Medicine|1986Cited by 441
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancerJane Blazeby, Corneel Coens, Thierry Conroy et al.|European Journal of Cancer|2004Cited by 225